http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP12012261-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2012-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32f65874f3dcca5ef4b8204afda04f0f |
| publicationDate | 2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EC-SP12012261-A |
| titleOfInvention | COMBINATIONS CONTAINING 2,3-DIHYDROIMIDAZO [1,2-C] REPLACED QUINAZOLINE |
| abstract | The present invention relates to: * combinations of: component A: one or more 2,3-dihydroimidazo [1,2-c] quinazoline compounds with the general formula (A1) or (A2), or a salt, solvate, hydrate or physiologically acceptable stereoisomer thereof; component B: one or more N- (2-arylamino) aryl sulfonamide compounds with the general formula (B), or Lapatinib, or Paclitaxel, or a salt, solvate, hydrate or stereoisomer thereof physiologically acceptable; and, optionally, component C: one or more additional pharmaceutical agents, where optionally any of the components or all of them is in the form of a pharmaceutical formulation ready for use to be administered simultaneously, concurrently, consecutively or separately. dependent on each other by the oral, intravenous, topical route, by local facilities, or by the intraperitoneal or nasal route; * use of such combinations for the preparation of a medicament to treat or for the prophylaxis of a type of cancer; and * a set of elements comprising a combination with said characteristics. |
| priorityDate | 2010-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.